Clinical Trials Browser

Carcinoma, Adenoid Cystic × Pemetrexed × 30 days × Clear all

NCT04895735 2026-06-04

MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

Phase 2 Active not recruiting

45 enrolled 12 charts

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms